share_log

Oppenheimer Upgrades AngioDynamics to Outperform, Announces $12 Price Target

Oppenheimer Upgrades AngioDynamics to Outperform, Announces $12 Price Target

奥本海默将AngioDynamics上调至跑赢大盘,宣布目标股价为12美元
Moomoo 24/7 ·  04/05 08:40

Oppenheimer analyst Steven Lichtman upgrades AngioDynamics (NASDAQ:ANGO) from Perform to Outperform and announces $12 price target.

奥本海默分析师史蒂芬·利希特曼将AngioDynamics(纳斯达克股票代码:ANGO)从表现上调至跑赢大盘,并宣布目标股价为12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发